Welcome to our dedicated page for Dupont De Nemours SEC filings (Ticker: DD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
DuPont de Nemours, Inc. filings document the regulatory disclosures of a Delaware specialty materials company with common stock listed on the New York Stock Exchange under DD. Its 8-K reports cover operating and financial results, Regulation FD disclosures, material events, board composition changes, corporate-governance matters and capital-structure disclosures.
DuPont proxy materials describe annual stockholder voting matters, director elections, governance practices, executive compensation and proposals affecting the company’s certificate of incorporation and common stock. Recent filings also document separation-related matters, including disclosures connected with the completed Qnity Electronics spin-off, as well as agreements and percentage calculations tied to the post-separation corporate structure.
DuPont de Nemours, Inc. CEO Lori Koch reported two common stock transactions. She had 4,672.5058 shares withheld at $48.03 per share to cover taxes on lapsed RSUs and related dividend-equivalent units, a non-market, compensation-related disposition. She also executed an open-market sale of 260.9784 shares at $48.82 per share within her 401(k) retirement savings plan. According to the disclosure, this 401(k) sale was voluntarily initiated ahead of the planned elimination of the company stock fund as an investment option, and the proceeds were immediately reinvested in other plan investment options. After these transactions, she directly holds 345,172.0573 shares and retains a very small indirect balance of 0.0204 shares in the retirement plan.
DuPont de Nemours, Inc. SVP & CFO Antonella B. Franzen reported a routine tax-withholding transaction related to equity compensation. On May 31, 2026, 1,558.1826 shares of DuPont common stock were disposed of at $48.03 per share to cover tax obligations on lapsed restricted stock units (RSUs) and related dividend equivalent units. This was not an open-market sale, but shares withheld by the issuer for taxes. After this transaction, Franzen directly holds 68,808.5975 shares of DuPont common stock.
DuPont de Nemours director Donald G. Macpherson received a stock award of 671.2102 shares of Common Stock on May 29, 2026, valued at $48.42 per share. This was a grant or other acquisition reported on Form 4 and is compensation-related rather than an open-market purchase. Following the award, he directly holds a total of 5,867.88 shares.
Lowery Frederick M. reported acquisition or exercise transactions in this Form 4 filing.
DuPont de Nemours, Inc. director Frederick M. Lowery received a stock award of 800.2891 shares of Common Stock. The shares were granted at a price of $48.42 per share as a compensation-related award, not an open-market purchase. After this grant, his directly held stake increased to 40,205.482 shares, indicating a relatively small, routine addition to his overall holdings.
DuPont de Nemours, Inc. director Alexander M. Cutler received a stock award of 1,032.6311 shares of Common Stock. The award was recorded at a value of $48.42 per share and is classified as a grant or other acquisition, not an open-market purchase.
Following this equity grant, Cutler directly holds a total of 81,794.4041 shares of DuPont Common Stock. This appears to be a routine compensation-related equity award that increases his ownership stake in the company.
DuPont de Nemours, Inc. director Donald G. Macpherson reported an acquisition of 4,030 shares of Common Stock. The shares were recorded at a price of $0.00 per share, reflecting a grant or award rather than an open-market purchase, and include shares acquired through dividend reinvestment. Following this award, his directly held position increased to 5,196.6698 shares of DuPont common stock, indicating a routine, compensation-related update to his equity holdings rather than a discretionary market trade.
BREEN EDWARD D reported acquisition or exercise transactions in this Form 4 filing.
DuPont de Nemours, Inc. director Edward D. Breen received an equity grant of 4,030 shares of Common Stock on May 21, 2026. The shares were awarded at a stated price of $0.0000 per share, reflecting a compensation-related grant rather than a market purchase.
Following this award, Breen directly holds 278,007.876 shares of DuPont common stock. This filing records a routine stock award to a board member, not an open-market transaction.
DuPont de Nemours director Kurt B. McMaken received 4,030 shares of Common Stock on May 21, 2026 as a grant or award, with shares also acquired through dividend reinvestment. The transaction carried a reported price of $0.00 per share.
Following this acquisition, McMaken directly owns about 8,257.8919 shares of DuPont de Nemours Common Stock. This is a compensation- and dividend-related share increase rather than an open‑market purchase or sale.
DuPont de Nemours, Inc. director Frederick M. Lowery reported an acquisition of company stock as a form of compensation and dividend reinvestment. He received a grant or award of 4,030 shares of Common Stock at a stated price of $0.00 per share, indicating a non-cash award rather than an open-market purchase.
After this transaction, Lowery directly held a total of 39,405.1929 shares of DuPont common stock. A footnote explains that the reported amount includes shares acquired through dividend reinvestment, showing that a portion of the increase reflects automatic reinvestment of dividends rather than discretionary market buying.
DuPont de Nemours, Inc. director James A. Lico reported an acquisition of company stock as compensation. On May 21, 2026, he received 4,030 shares of common stock in a grant/award acquisition, including shares obtained through dividend reinvestment. Following this award, he directly holds 10,839.1156 shares of DuPont common stock.